Showing results (121-130 of 271) with videos related to
Sort By:
Pageof 28
Genes & Development|December 15, 2025
Mutant p53: evolving perspectivesGizem Efe, Katherine Cunningham, Anil K Rustgi, et al.Oncogene|February 19, 2002
Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosisTanya M Gottlieb, Juan Fernando Martinez Leal, Rony Seger, et al.Molecular Cancer Research : MCR|February 23, 2024
Systematic Characterization of p53-Regulated Long Noncoding RNAs across Human Cancers Reveals Remarkable Heterogeneity among Different Tumor TypesKausik Regunath, Vitalay Fomin, Zhaoqi Liu, et al.Molecular Cell|May 2, 2002
Cyclin G recruits PP2A to dephosphorylate Mdm2Koji Okamoto, Hongyun Li, Michael R Jensen, et al.Plos One|December 31, 2009
Discovery of novel proteasome inhibitors using a high-content cell-based screening systemIrena Lavelin, Avital Beer, Zvi Kam, et al.Oncotarget|June 14, 2019
Correction: Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptidesPerry Tal, Shay Eizenberger, Elad Cohen, et al.Nature Protocols|March 27, 2015
Simultaneous measurement of genome-wide transcription elongation speeds and rates of RNA polymerase II transition into active elongation with 4sUDRB-seqGilad Fuchs, Yoav Voichek, Michal Rabani, et al.Oncotarget|June 17, 2021
Frame-shift mediated reduction of gain-of-function p53 R273H and deletion of the R273H C-terminus in breast cancer cells result in replication-stress sensitivityViola Ellison, George K Annor, Clara Freedman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancerPere Puig, Paola Capodieci, Marija Drobnjak, et al.Cancer Discovery|May 16, 2012
Discovery of Mdm2-MdmX E3 ligase inhibitors using a cell-based ubiquitination assayAriel G Herman, Miki Hayano, Masha V Poyurovsky, et al.Pageof 28